26739
The impact of folic acid supplementation on gestational and long term health: Critical temporal windows, benefits and risksCarla Silva, Elisa Keating, Elisabete Pinto
Porto Biomed J. 2017;2:315-32
26739
Highlights
- •
Associations between FA supplementation in pregnancy and effects on offspring's NTDs, allergy/respiratory problems, cancer and behaviour problems as been studied.
- •
There is growing concern about the effects of excessive FA supplementation, whether in terms of doses or times of exposure.
- •
FA supplementation in the periconceptional period is protective against NTDs while in later periods it could be deleterious.
- •
A daily dose of 0.4mg FA in the periconceptional period seems to be effective and safe.
19581
Rituximab in generalized myasthenia gravis: Clinical, quality of life and cost–utility analysisJoão Peres, Rita Martins, José Delgado Alves, Ana Valverde
Porto Biomed J. 2017;2:81-5
19581
Highlights
- •
Rituximab use in MG patients lead to the reduction of relapses and to a lesser use of immunosuppressive agents in our series.
- •
Rituximab use in our MG patients decreased healthcare costs after treatment, comparing to the pre-treatment period.
- •
Rituximab is a clinical effective treatment for B cell-related diseases like MG and seems to be a cost–saving intervention.
12793
Botulinum toxin improves pain in chronic anal fissureHugo Amorim, José Santoalha, Rui Cadilha, Maria-José Festas, Paula Barbosa, Armanda Gomes
Porto Biomed J. 2017;2:273-6
12793
Highlights
- •
Chronic anal fissure is a common condition associated with intense pain.
- •
Local botulinum toxin injection is a valid option in its management.
- •
Pain intensity scores significantly improved after BoNT injection.
- •
Side effects were rare and mild.
- •
Our results support the inclusion of BoNT in the management algorithm of chronic anal fissure.
9640
Regulation of colonic epithelial butyrate transport: Focus on colorectal cancerPedro Gonçalves, Fátima Martel
Porto Biomed J. 2016;1:83-91
9640
Highlights
- •
Fermentation of the dietary fiber by intestinal microflora results in production of butyrate.
- •
Butyrate possesses anticarcinogenic effect at the colonic level.
- •
Three transporters (MCT1, SMCT1 and BCRP) regulate the intracellular concentration of BT in colonic epithelial cells.
- •
Changes in the expression of these transporters occur in colorectal cancer.